GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Qianjiang Yongan Pharmaceutical Co Ltd (SZSE:002365) » Definitions » Shiller PE Ratio

Qianjiang Yongan Pharmaceutical Co (SZSE:002365) Shiller PE Ratio : 21.44 (As of Jun. 05, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Qianjiang Yongan Pharmaceutical Co Shiller PE Ratio?

As of today (2024-06-05), Qianjiang Yongan Pharmaceutical Co's current share price is ¥7.29. Qianjiang Yongan Pharmaceutical Co's E10 for the quarter that ended in Mar. 2024 was ¥0.34. Qianjiang Yongan Pharmaceutical Co's Shiller PE Ratio for today is 21.44.

The historical rank and industry rank for Qianjiang Yongan Pharmaceutical Co's Shiller PE Ratio or its related term are showing as below:

SZSE:002365' s Shiller PE Ratio Range Over the Past 10 Years
Min: 18.88   Med: 31.49   Max: 46.77
Current: 21.44

During the past years, Qianjiang Yongan Pharmaceutical Co's highest Shiller PE Ratio was 46.77. The lowest was 18.88. And the median was 31.49.

SZSE:002365's Shiller PE Ratio is ranked better than
55.6% of 536 companies
in the Drug Manufacturers industry
Industry Median: 23.89 vs SZSE:002365: 21.44

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Qianjiang Yongan Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2024 was ¥0.097. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ¥0.34 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Qianjiang Yongan Pharmaceutical Co Shiller PE Ratio Historical Data

The historical data trend for Qianjiang Yongan Pharmaceutical Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qianjiang Yongan Pharmaceutical Co Shiller PE Ratio Chart

Qianjiang Yongan Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 33.48 30.31 32.97 30.59 29.80

Qianjiang Yongan Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.98 27.60 29.27 29.80 21.85

Competitive Comparison of Qianjiang Yongan Pharmaceutical Co's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Qianjiang Yongan Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qianjiang Yongan Pharmaceutical Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Qianjiang Yongan Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Qianjiang Yongan Pharmaceutical Co's Shiller PE Ratio falls into.



Qianjiang Yongan Pharmaceutical Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Qianjiang Yongan Pharmaceutical Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=7.29/0.34
=21.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Qianjiang Yongan Pharmaceutical Co's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Qianjiang Yongan Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.097/115.2271*115.2271
=0.097

Current CPI (Mar. 2024) = 115.2271.

Qianjiang Yongan Pharmaceutical Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 0.060 98.200 0.070
201409 0.040 98.900 0.047
201412 0.005 99.000 0.006
201503 0.000 99.900 0.000
201506 0.022 99.500 0.025
201509 0.020 100.500 0.023
201512 -0.007 100.600 -0.008
201603 0.033 102.200 0.037
201606 0.087 101.400 0.099
201609 0.060 102.400 0.068
201612 0.040 102.600 0.045
201703 0.087 103.200 0.097
201706 0.163 103.100 0.182
201709 0.170 104.100 0.188
201712 0.047 104.500 0.052
201803 0.231 105.300 0.253
201806 0.206 104.900 0.226
201809 0.160 106.600 0.173
201812 0.094 106.500 0.102
201903 0.023 107.700 0.025
201906 0.087 107.700 0.093
201909 0.120 109.800 0.126
201912 0.070 111.200 0.073
202003 0.017 112.300 0.017
202006 0.313 110.400 0.327
202009 0.070 111.700 0.072
202012 -0.034 111.500 -0.035
202103 0.027 112.662 0.028
202106 0.133 111.769 0.137
202109 0.130 112.215 0.133
202112 0.086 113.108 0.088
202203 0.165 114.335 0.166
202206 0.235 114.558 0.236
202209 0.150 115.339 0.150
202212 -0.074 115.116 -0.074
202303 0.051 115.116 0.051
202306 0.139 114.558 0.140
202309 -0.030 115.339 -0.030
202312 -0.202 114.781 -0.203
202403 0.097 115.227 0.097

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Qianjiang Yongan Pharmaceutical Co  (SZSE:002365) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Qianjiang Yongan Pharmaceutical Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Qianjiang Yongan Pharmaceutical Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Qianjiang Yongan Pharmaceutical Co (SZSE:002365) Business Description

Traded in Other Exchanges
N/A
Address
No. 2, Guangze Avenue, Qianjiang Economic Development Zone, Hubei Province, Wuhan, CHN, 433100
Qianjiang Yongan Pharmaceutical Co Ltd is a China-based company principally involved in the manufacturing of taurine products. The company sells its products in China and other international countries.
Executives
Mei Song Lin Executives
Wang Zhi Hua Executives
Hong Ren Gui Executives
Wu Yu Xi Directors, executives
Dai Xiang Zhen Executives
Wu Xiao Bo Directors, executives
Luo Bai Neng Executives
Ding Hong Li Directors, executives
Fang Xi Quan Executives
Li Shao Bo Executives
Deng Yong Hong Securities Affairs Representative
Dong Shi Hao Executives
Wu Guo Sen Supervisors
Lv Xin Wu Executives
Chen Yong Directors, executives

Qianjiang Yongan Pharmaceutical Co (SZSE:002365) Headlines

No Headlines